| Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. P McLaughlin, AJ Grillo-Lopez, BK Link, R Levy, MS Czuczman, ... Journal of clinical oncology 16 (8), 2825-2833, 1998 | 3625 | 1998 |
| Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases TJ Walsh, JW Hiemenz, NL Seibel, JR Perfect, G Horwith, L Lee, JL Silber, ... Clinical Infectious Diseases 26 (6), 1383-1396, 1998 | 785 | 1998 |
| Posterior reversible encephalopathy syndrome in infection, sepsis, and shock WS Bartynski, JF Boardman, ZR Zeigler, RK Shadduck, J Lister American Journal of Neuroradiology 27 (10), 2179-2190, 2006 | 564 | 2006 |
| Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis JR Wingard, P Kubilis, L Lee, G Yee, M White, W Louise, R Bowden, ... Clinical infectious diseases 29 (6), 1402-1407, 1999 | 479 | 1999 |
| Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes KE Salhany, WR Macon, JK Choi, R Elenitsas, SR Lessin, RE Felgar, ... The American journal of surgical pathology 22 (7), 881-893, 1998 | 415 | 1998 |
| Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin’s lymphoma TE Witzig, CA White, LI Gordon, GA Wiseman, C Emmanouilides, ... Journal of Clinical Oncology 21 (7), 1263-1270, 2003 | 375 | 2003 |
| High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome–negative acute lymphoblastic leukemia S O'Brien, G Schiller, J Lister, L Damon, S Goldberg, W Aulitzky, ... Journal of clinical oncology 31 (6), 676, 2013 | 207 | 2013 |
| Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity WS Bartynski, Z Zeigler, MP Spearman, L Lin, RK Shadduck, J Lister American Journal of Neuroradiology 22 (10), 1901-1914, 2001 | 188 | 2001 |
| Activity of azacitidine in chronic myelomonocytic leukemia R Costa, H Abdulhaq, B Haq, RK Shadduck, J Latsko, M Zenati, FD Atem, ... Cancer 117 (12), 2690-2696, 2011 | 168 | 2011 |
| Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation JE Kiss, WB Rybka, A Winkelstein, M deMagalhaes-Silverman, J Lister, ... Bone marrow transplantation 19 (4), 303-310, 1997 | 164 | 1997 |
| Ex vivo expansion of human umbilical cord blood and peripheral blood CD34+ hematopoietic stem cells GL Gilmore, DK DePasquale, J Lister, RK Shadduck Experimental Hematology 28 (11), 1297-1305, 2000 | 142 | 2000 |
| A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory … F Morschhauser, O Fitoussi, C Haioun, C Thieblemont, H Quach, ... European journal of cancer 49 (13), 2869-2876, 2013 | 136 | 2013 |
| Amphotericin B lipid complex (Abelcet®) in the treatment of invasive mycoses: the North American experience J Lister European Journal of Haematology 56 (S57), 18-23, 1996 | 111 | 1996 |
| Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period. J Lister, WB Rybka, AD Donnenberg, M deMagalhaes-Silverman, ... Clinical cancer research: an official journal of the American Association …, 1995 | 109 | 1995 |
| Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer M deMagalhaes-Silverman, A Donnenberg, B Lembersky, E Elder, ... Journal of Immunotherapy 23 (1), 154-160, 2000 | 106 | 2000 |
| Treatment of acute myelogenous leukemia with outpatient azacitidine N Sudan, JM Rossetti, RK Shadduck, J Latsko, JA Lech, RB Kaplan, ... Cancer 107 (8), 1839-1843, 2006 | 99 | 2006 |
| An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes SL Goldberg, P Fenaux, MD Craig, E Gyan, J Lister, J Kassis, A Pigneux, ... Leukemia research reports 3 (2), 58-61, 2014 | 93 | 2014 |
| The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis KM Williams, KW Ahn, M Chen, MD Aljurf, AL Agwu, AR Chen, TJ Walsh, ... Bone marrow transplantation 51 (4), 573-580, 2016 | 85 | 2016 |
| Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation WS Bartynski, ZR Zeigler, RK Shadduck, J Lister American journal of neuroradiology 25 (2), 261-269, 2004 | 85 | 2004 |
| Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma AA Chanan-Khan, R Niesvizky, RJ Hohl, TM Zimmerman, ... Leukemia & lymphoma 50 (4), 559-565, 2009 | 76 | 2009 |
